169 related articles for article (PubMed ID: 37132252)
21. Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer.
Lee YC; Shin SY; Kwon KH; Eun YG
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2547-50. PubMed ID: 23553243
[TBL] [Abstract][Full Text] [Related]
22. Papillary Thyroid Cancers of the Thyroid Isthmus: The Pattern of Nodal Metastasis and the Significance of Extrathyroidal Extension.
Seok J; Choi JY; Yu HW; Jung YH; Ahn SH; Jeong WJ
Ann Surg Oncol; 2020 Jun; 27(6):1937-1944. PubMed ID: 31970571
[TBL] [Abstract][Full Text] [Related]
23. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
24. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas.
Pyo JS; Sohn JH; Kang G; Kim DH; Yun J
Yonsei Med J; 2015 Mar; 56(2):355-61. PubMed ID: 25683981
[TBL] [Abstract][Full Text] [Related]
25. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
26. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
[TBL] [Abstract][Full Text] [Related]
27. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
29. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
Wu Y; Li J; Wu X; Dai L
Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
[TBL] [Abstract][Full Text] [Related]
30. Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results.
Chen Q; Liu Y; Lu W; Zhang L; Su A; Liu F; Zhu J
Front Endocrinol (Lausanne); 2022; 13():921845. PubMed ID: 35923620
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic characteristics and pattern of central lymph node metastasis in papillary thyroid cancer located in the isthmus.
Lee YC; Na SY; Chung H; Kim SI; Eun YG
Laryngoscope; 2016 Oct; 126(10):2419-21. PubMed ID: 27098428
[TBL] [Abstract][Full Text] [Related]
33. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
34. [Establishment of model to predict lateral neck recurrence of central lymph node metastasis in papillary thyroid carcinoma].
Xu SY; Ren ZF; Liu J; Huang H; Zhang ZM; Liu SY; Wang XL; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):775-780. PubMed ID: 34289572
[No Abstract] [Full Text] [Related]
35. Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma.
Zhou M; Duan Y; Ye B; Wang Y; Li H; Wu Y; Chen P; Zhu J; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2022; 13():914946. PubMed ID: 35923627
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
[TBL] [Abstract][Full Text] [Related]
37. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
38. The total number of prelaryngeal and pretracheal lymph node metastases: is it a reliable predictor of contralateral central lymph node metastasis in papillary thyroid carcinoma?
Chen Q; Wei T; Wang XL; Li ZH; Du ZH; Zhu JQ
J Surg Res; 2017 Jun; 214():162-167. PubMed ID: 28624039
[TBL] [Abstract][Full Text] [Related]
39. Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer.
Seok J; Ryu CH; Park SY; Lee CY; Lee YK; Hwangbo Y; Lee EK; Lee YJ; Kim TS; Kim SK; Jung YS; Ryu J
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):519-527. PubMed ID: 33560176
[TBL] [Abstract][Full Text] [Related]
40. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
